Form 8-K - Current report:
SEC Accession No. 0000950103-26-007158
Filing Date
2026-05-13
Accepted
2026-05-13 16:22:27
Documents
14
Period of Report
2026-05-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K dp246650_8k.htm   iXBRL 8-K 24473
2 EXHIBIT 99.1 dp246650_ex9901.htm EX-99.1 69910
6 GRAPHIC image_005.jpg GRAPHIC 1801
7 GRAPHIC image_006.jpg GRAPHIC 1801
  Complete submission text file 0000950103-26-007158.txt   274462

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE pgen-20260513.xsd EX-101.SCH 2999
4 XBRL LABEL FILE pgen-20260513_lab.xml EX-101.LAB 34239
5 XBRL PRESENTATION FILE pgen-20260513_pre.xml EX-101.PRE 22348
17 EXTRACTED XBRL INSTANCE DOCUMENT dp246650_8k_htm.xml XML 3079
Mailing Address 20374 SENECA MEADOWS PARKWAY GERMANTOWN MD 20876
Business Address 20374 SENECA MEADOWS PARKWAY GERMANTOWN MD 20876 301-556-9900
PRECIGEN, INC. (Filer) CIK: 0001356090 (see all company filings)

EIN.: 000000000 | State of Incorp.: VA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36042 | Film No.: 26973711
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)